SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " pharma " 701 found 🔀 AI-powered Shuffle
Amazon One Medical introduces weight management program with upfront GLP-1 medication costs
The new program combines primary care, pharmacy, and virtual options to treat obesity as a chronic condition—all in one place.
Holland & Knight Health Dose: April 21, 2026 | Insights
Senate HELP Committee Chair Bill Cassidy released a healthcare agenda to expand TrumpRx, increase price transparency and regulate pharmacy benefit managers (PBMs).
McLeod Health Pharmacy Services Team Receives Best Practice Award
The McLeod Health Pharmacy Services Team recently received the “Practice Advancement Initiative – Best Practice Award” during the South Carolina Society of Health-Systems
Blue Shield of California Announces New Leader to Drive Nonprofit Health Plan’s Innovative Pharmacy Services for Members
“What drew me to Blue Shield is that it’s a mission-driven nonprofit health plan that’s committed to improving member health and their lives — not just lowering costs for medications.”
Drug ads face new scrutiny at FDA and on Hill
The U.S. and New Zealand are the only countries that allow direct-to-consumer pharmaceutical advertising.
Ryan Reynolds on Business Ventures, Blake Lively and ‘Deadpool’
In part one of this Sunday Sitdown Live, Ryan Reynolds joins Willie Geist in front of a packed crowd to discuss the rapid rise of Wrexham A.F.C., his many business ventures like his Maximum Effort, the young audience he’s found at home for his “Deadpool” franchise and what’s next for the superhero. Reynolds also shares support for his wife Blake Lively and reveals how he is feeling about his upcoming 50th birthday milestone. (Sponsored by More to Parkinson’s and brought to you by Acadia Pharmaceuticals Inc. Venue sponsored by City Winery)
Walmart to remodel nine NH stores; add pharmacy in Keene
Walmart plans to remodel nine stores in New Hampshire this year and open a new pharmacy in Keene, the company announced Thursday.
Xanax XR recalled after discovery that tablets may fail to release medication properly
A batch of Xanax XR has been recalled nationwide after the manufacturer found the drug may not release properly in the body. The FDA classified the issue as moderate risk.
Tiger Woods fights attempts to subpoena his pharmacy records
Prosecutors are seeking to obtain Woods' prescription drug records in wake of rollover accident.
Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
Tivoxavir marboxil advancing towards a human influenza challenge trial as a once-monthly prophylactic agent, building on broad preclinical antiviral activity, Ratutrelvir topline Phase 2a data show a differentiated profile versus PAXLOVID® in COVID patients, with good overall safety; final study analysis underway Private financing of up to $60M (with $10M of such amount upfront) offering of common stock and milestone-based and three-year warrants completed on April 15, 2026 supporting operations
RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals
A panel of outside advisers will review seven peptides at a meeting in July to determine if the unapproved drugs can be safely produced by pharmacies.
Lena Dunham on New Memoir, Jack Antonoff, Health Issues, More
Writer, director, and actor Lena Dunham joins TODAY’s Jenna Bush Hager and Sheinelle Jones to talk about her new memoir, “Famesick: A Memoir,” where she opens up about her health, experience with fame, and what it means to come of age under the intense scrutiny of Hollywood. Dunham talks about the negative attention she got while starring in “Girls” and how it exacerbated her health issues, reflects on her breakup with Jack Antonoff, and opens up about her battle with pharmaceutical dependency. Dunham also shares the story of how she came to the decision to get a hysterectomy when her endometriosis became unbearable, despite her dreams of being a mother.
He Has a War Chest and an ‘R’ by His Name. Will Enough Voters Like Him?
Vivek Ramaswamy has all but cleared the field ahead of the May primary for Ohio governor, but whether a finance and pharma billionaire is the man for the moment is another question.
Community Routes: Access to Mental Health Care Program Bolsters Services Across Three States
Direct Relief, Teva Pharmaceuticals, and the National Association of Free and Charitable Clinics, or NAFC, today announced a second round of grant funding in the amount of $75,000 to each of 11 fre…
FDA accepts previously rejected application for new PET imaging agent
The radiopharma firm hopes to soon begin selling Pixclara (Floretyrosine F 18), an investigational product for glioma, a type of brain cancer.
ON THE JOB: “What is the Best Business Advice You’ve Ever Received?
Interviews by Deborah Jeanne Sergeant Sound advice can contribute to your success. We recently asked area business leaders, what was their best advice they’d ever received. Here’s what they said: “The best advice I ever received was from my then –boss, Gerry Church, Fulton plant manager at Miller Brewing Co. He told me that whenever I wanted to discuss a business problem or issue with him, I should also be prepared to offer possible solutions. It’s the difference between being proactive or reactive. It’s also the difference between being a leader or follower. That has served me well in any business relationship I have had since then.” — Stephen Chirello, Owner, Steve Chirello Advertising, Fulton “Someone will always do it for less; they will also take the most effort to service or satisfy and leave you for the next lower price.” — John M. Henry, Owner, Speedway Press, Mitchell Printing, Phoenix Press, Oswego “I’m going to answer this question by turning it around and giving my own advice that is, ‘Always treat every customer as if they were your only customer!’ We are celebrating our 50th anniversary in business this year. We started our business on March 25, 1976. My advice works.”” — Nick Chervinsky, President, Brewerton Pharmacy, Brewerton “’You need to toot your own horn, my grandfather, Howard D. Dice, told me.” — Beth Ann Dice, Women’s active aging and cancer recovery coach, Mission Movement Wellness Studio & Breast Cancer Recovery Studio, Fulton “In the micro enterprise class, they taught, ‘Get a good lawyer, accountant and bank.’ That was over 30 years ago and I still have those three today. I chose good people I could grow with.” — Tony Pauldine, Owner, Anthony M. Pauldine General Contractors Inc., Oswego “From my grandfather; ‘Listen to everyone! You never know where you will get the solution you need.’” — Kevin Dean, Executive director, Oswego County Opportunities, Fulton “‘Preparation is the mother of success.’ My dad always drilled that into my head growing up, and it has helped me avoid a lot of snags in both my personal and professional life. Thanks, Dad!” — Bekkah Frisch, Owner and president, iHeart Holdings, Inc., Fulton “If you don’t take a risk and try, you will never know.” — Justin Taber, Owner, Torbitt’s Service Center, Oswego “Be ready to take a loss.” — Cody Seymour, Manager, Damiano’s Eatery, Mexico “I’ve received so much good business advice over the years. When people are giving you advice, always be curious rather than judgmental. Follow your gut. Doing the right thing is never the wrong thing.” — Dana Decker, Principal owner/broker, Berkshire Hathaway Home Services, Oswego ’Do it and figure it out later.’ It hasn’t failed me yet. Too many people take time to think about doing this and this and this and then the opportunity is over with. If it’s somewhat reasonable — if it’s not something outrageous — do it and figure it out later.” — Jeremy Allen, Licensed real estate salesperson, Acropolis Realty Group, Syracuse “’Try to meet the needs of the customer. Treat them like you’d like to be treated.’ It’s like the Golden Rule says.” — Douglas Dickson, Physician and associate at CNY Foot Surgery and Podiatry Care, East Syracuse “The best piece of business advice I’ve ever received applies to life in general: always be honest. Never overstate your capabilities and always be willing to ask questions. The more specific you can be in any given topic will always lead to a better outcome.” — Tom Fernandez, President, Woodbine Hospitality, Syracuse “As a business owner, the advice would be ‘Don’t overextend yourself. Especially in agriculture, expect issues to come up.’ If something is going right, it’s not true agriculture. This last season, we scaled very hard to field another crew. We got more drones, crew and generators based on projections. This last season hit the ag community hard with a very wet spring. We did 15,000 to 20,000 acres for fungicide and the same for cover crop seeding in 2024. We scaled to 25,000 to 30,000 for 2025. We ended up doing 2,000 for fungicide and 3,000 for cover crop seeding. That’s why that advice was good.” — Rick Jordan, Operations manager, CNY Drove Services, Clinton “’Keep your head down, mind your own business and do the best for your clients that you can do.’ It has a lot to do with my success in working for Galloway Century 21.” — Ed Fayette, New York state licensed real estate agent, Century 21 Galloway, Oswego “’Expand in all ways, always.’ It just keeps you going and keeps you growing.” — Stephen Baier, Licensed real estate person, The Real Estate Agency & Bouck Commercial, Auburn “The best advice is, ‘Your biggest asset you won’t see on the books because it comes from your employees.’” — David Flickinger, Owner, Edible Arrangements, Syracuse “Don’t take things personally when you’re working with the public.” — Leeann Desimone, Manager, Annie’s Hallmark Shop, Auburn “‘Follow up.’ The customer knows that you care about what you are doing and that their opinion counts. Sometimes they might be on the fence about whether they want to use your company. If they’re asking your opinion on things, they feel you are concerned about what you’re doing. They like to be kept in the loop if they’re spending money with you.” — Dorothy Casper, Saslesperson, SweetWoods Memorials, Phoenix “The best business advice I received is ‘Never be the smartest person in the room. Surround yourself with people who are smarter than you.’ That’s how you learn.” — Debbie Bilello, Owner, Virtual Office Solutions, Central Square “’You need to grow your business but you can’t grow too big too fast.’ That’s what we’ve done at Pinnacle Maintenance. We’ve tried to grow but not too fast. Along those same lines, there’s another good piece of advice, ‘Don’t take on more than you can handle because it only leads to a bad name for your business and a bad experience for your customers.’ It goes along the same lines as growing your business slowly and carefully.” — David Wines, Owner, Pinnacle Maintenance, Central Square “Always be on time and do what you say you are going to do.’ I’ve done very well following that advice. Most of my work is referral and I don’t really do any advertising so I have a pretty good customer base. It’s mostly word-of-mouth from satisfied customers.” — Robert J. Fleming, Owner, Bob Fleming Windows & Doors, Brewerton “’Concentrate on your finances, always pay your taxes, and form a team you can depend on. Try to help the community you’re in as much as you can.’ We do all of these all the time here. We give and give and give to the community and the community gives back to us always.” — Susan Bonnet, Co-owner, Bonnet Sales and Service, Central Square “Keep smiling. It brings a positive attitude to the workplace.” — Karin Lindsley, Vice president, DTS Truck Service, Syracuse “‘Customer service above all.’ Following this advice has served us very well.’ — Guy Fox, Owner, Fox’s Discount Parts, West Monroe “The best thing to do is to make sure you’re taking in more money than you’re spending. I wish I could say I’m a good businessman but I have been in business since 1981. I’m not a bean counter but work well with my hands and its’s served me well all these years and I am still in business.” — Matt McGill, Owner, Matt McGill Collision, Brewerton
WesternU College of Pharmacy’s Ray Symposium examines keys to regain trust in science
Dr. Aaron E. Carroll, President & CEO of AcademyHealth, presented “Science You Can Trust: Leading with Evidence in a Distrustful Time” at the 20th annual Ray Symposium at WesternU.
This Women’s Health Company Is Drawing Takeover Interest. The Stock Is Soaring.
Organon stock jumped after a report said Sun Pharmaceutical Industries is nearing an all-cash deal for the women’s health company.
This Women’s Healthcare Stock Is Up 15% on Reports of a Takeover In the Works
Organon shares surged Friday following reports India’s Sun Pharmaceutical made a bid for the women's healthcare company.
Chinese business ‘hired lobbying firm with ties to Donald Trump Jnr’
Lobbying firm Checkmate helped China’s Grand Pharmaceutical Group beat a US national security challenge, public filings show.
Kansas City health leaders announce new integrated theranostics research and treatment center
The center will unite diagnostics, molecular imaging, radiopharmaceutical production and targeted therapies under one coordinated platform.
FDA rejects an industry proposal to deregulate some AI devices
In this edition of Health Tech: FDA rejects a proposal to deregulate certain types of AI devices, pharma invests $50 million in DTx, and more.
Pardee Rx Community Pharmacy Opens on Brevard Campus
Pardee Rx Community Pharmacy Opens on Brevard Campus
Amazon Pharmacy to Offer Eli Lilly and Company’s New GLP-1 Pill Foundayo via Same-Day Delivery
Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that offers fast medication delivery directly to customers' homes, now offers Eli Lilly and C...
BYU-Idaho Students Accepted to Health Professional Schools at Above-Average Rates
BYU-Idaho students applying to professional health programs during the 2024–2025 cycle achieved high acceptance rates to various medical schools.
Washington’s most powerful drug industry lobbyist is stepping down
Steve Ubl built PhRMA into a more aggressive operation as its longtime leader. The White House has tangled with Ubl and the pharmaceutical industry in its bid to lower drug prices.
This week in Santa Cruz County business: County reaches settlement with Walgreens; businesses invited to partake in World Cup promotions
Jessica M. Pasko's weekly column returns with news of Santa Cruz County getting more than half a million from pharmacy giant Walgreens and local businesses' chance to get in on World Cup fever, plus names, numbers and dates to know.
Trump’s Personnel Agency Is Asking for Federal Workers’ Medical Records
The administration is asking insurers that cover federal employees and retirees to hand over details about their medical visits, their pharmacy claims, and more.
Immunic COO highlights the importance of science-led innovation to mark World Health Day
Immunic Inc (NASDAQ:IMUX, FRA:10VA) chief operating officer Jason Tardio talked with Proactive's Stephen Gunnion about the importance of science-led innovation in tackling neurological diseases, particularly multiple sclerosis, on World Health Day 2026. Tardio highlighted that the biotech industry is fundamentally grounded in scientific research and data, noting that “everything we do is rooted in science.” He explained that Immunic is focused on developing innovative therapies designed to improve patient outcomes and address significant unmet medical needs. The discussion centred on multiple sclerosis (MS), a complex neurological disease that continues to present challenges despite decades of progress. Tardio pointed out that while advancements have been made, “the disease is not solved for,” with many patients still experiencing disability progression and requiring safer, more tolerable treatments. He emphasised the urgent need for innovation, particularly in progressive forms of MS where treatment options remain extremely limited. Immunic’s lead asset, vidofludimus calcium, is being developed as a novel approach aimed at addressing the full spectrum of the disease. Tardio also reinforced the broader mission of the healthcare and biotech sectors, stating that the ultimate goal is to help individuals “live a better quality of life” and “a healthier life longer.” Watch the full interview to learn more about Immunic’s approach to advancing MS treatment through science. For more videos like this, visit Proactive's YouTube channel, like this video, subscribe to the channel, and enable notifications so you never miss an update. #Immunic #MultipleSclerosis #BiotechInnovation #Healthcare #MSResearch #DrugDevelopment #ClinicalTrials #Neurology #WorldHealthDay #ScienceDriven #VidofludimusCalcium #PharmaNews #BiotechNews
Losing Health Coverage Due to Trump Cuts? Your Guide on ‘Essential Plan’ Changes
About 450,000 New Yorkers are set to lose their health insurance July 1. Here’s what experts say you should do to prepare now.
Spanberger signs bipartisan bills tied to billions in business investment across Virginia
Gov. Abigail Spanberger on Monday signed a package of economic development bills aimed at securing billions of dollars in private investment and creating thousands of jobs across Virginia, highlighting projects in Southside and Central Virginia tied to manufacturing, energy infrastructure and pharmaceuticals.The legislation supports several major projects announced by the administration in February, including a more than $500 million investment in Pittsylvania County by Avio USA Inc. The company plans to build an 860,000-square-foot manufacturing facility at the Southern Virginia Multimodal Park in the town of Hurt.
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
Anthropic in October last year iterated its Claude AI model to better cater to biopharma purposes. Sanofi, Novo Nordisk, AbbVie and others already use Claude in their operations.
Ohio’s First Forensic Toxicology Master’s Program Opens for Enrollment at UToledo
The online program, which now has state approval, is built on UToledo’s “deep toxicology and pharmacology foundation.”
Health Care Roundup: Market Talk
Find insight on Eli Lilly, Hansoh Pharmaceutical Group and more in the latest Market Talks covering the Health Care sector.
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and patented drugs.
Trump signs 100% tariff on brand-name pharmaceuticals
Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower prices.
Iterative Health, US Heart & Vascular Partner to Advance Community-Based Cardiovascular Research
April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance research through community-based innovation in cardiovascular care. "Clinical research is one of the most powerful ways we expand access, improve patient outcomes, and shape the future of cardiovascular care," said Robbie Allen, chief executive officer of US Heart & Vascular. "By partnering with Iterative Health, we are strengthening our ability to bring innovative therapies directly into the communities we serve. This collaboration ensures our physicians and patients have access to leading-edge trials while allowing US Heart & Vascular to remain focused on delivering exceptional, physician-led care." Under the agreement, USHV research sites will join Iterative Health’s global site network, which now spans over 100 sites across three continents. The companies share a commitment to advancing clinical research as a driver of care innovation, and this collaboration represents a major milestone for both organizations, strengthening USHV's leadership in community-based cardiovascular research and expanding Iterative Health's multispecialty focus beyond GI, hepatology, and obesity into cardiology. USHV clinical research sites will gain access to Iterative Health's centralized operational backbone, providing end-to-end support across clinical research operations, services, business development, technology innovation, and corporate functions. The strategic partnership reduces operational complexity and unlocks growth potential for USHV research sites while enabling all USHV physicians to expand access to cutting-edge therapies to the thousands of patients they serve annually. "Innovation in cardiovascular medicine shouldn't be limited to a few academic centers," said Thomas Waggoner, DO, MD, RPVI, FACC, FSCAI, FSVM, RPVI, Structural Cardiologist and Medical Director for Clinical Research at Pima Heart & Vascular, and USHV Physician Champion for Clinical Research. "By expanding community-based research across USHV, we're ensuring more patients have access to clinical trials and breakthrough therapies close to home, where trusted relationships with their physicians already exist." This alliance reinforces Iterative Health's standing as the definitive research partner across specialized therapeutic areas, now spanning GI, hepatology, obesity, and cardiovascular care. Trusted by many of the nation's leading provider organizations and biopharma sponsors, Iterative Health's global site network delivers industry-leading trial performance, accelerating life-changing therapies to market at scale. "Entering cardiology through our strategic partnership with US Heart & Vascular is a defining moment for Iterative Health and reflects the strength of our site-serving model," said Jonathan Ng, founder and CEO of Iterative Health. "Together, we are ensuring that thousands of patients have access to the newest available therapies, and that sponsors have a credible, high-performing partner to accelerate cardiovascular trial success." For more information, visit www.iterative.health and https://usheartandvascular.com/.
Walgreens’ private equity owner plans to double pharmacy chain’s profits
Sycamore Partners, a New York-based buyout firm, wants to grow the retailer’s earnings before interest, taxes, depreciation, and amortization to $4 billion.
Trump expected to impose new tariffs on certain pharmaceutical drugs
President Donald Trump plans to impose new tariffs on pharmaceutical companies that have not struck deals to sell their drugs directly to consumers as part of his “Most Favored Nation” pricing initiative, according to a draft of an order obtained by CNN.
Merck KGaA acquires JSR chromatography business
Merck KGaA has completed its previously announced acquisition of the chromatography business of JSR Life Sciences.
Global Industrie - What are the changes in the health care sector?
Discover the major changes reshaping the global health care sector, driven by geopolitics, innovation and new pharmaceutical industry models.
The future of space business depends on a rocket that keeps blowing up
Dozens of startups working on data centers, mining and pharmaceuticals are hanging on Elon Musk's long-stalled megarocket.
Back to Business Program helps Quynh’s Pharmacy continue serving Little Saigon community
Quynh’s Pharmacy is a fixture in Little Saigon. The owner, Mary Bui, is also a fixture within the pharmacy, having worked there for three decades. When vandals broke the glass entry door and both security gates, Bui faced a steep bill to repair the damages. “They charged over $6,000,” she explained. “We had to do […]
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes
The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
BrightSpring Health Services Completes Sale of ResCare Community Living to Sevita
LOUISVILLE, Ky., March 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based pharmacy and health services for complex populations, today announced the completed sale of ResCare Community Living to Sevita, a leading provider of home and community-based specialty health care. The transaction reflects a shared commitment to continuity of care, operational stability, and long-term opportunity f
The future of space business depends on a rocket that keeps blowing up
Dozens of startups working on data centers, mining and pharmaceuticals are hanging on Elon Musk's long-stalled megarocket.
Mount Sinai Health System Collaborates with OpenEvidence to Provide Evidence-Based Knowledge Within Electronic Medical Record
Collaboration extends access to all clinical users, including nurses and pharmacists
THE POLICY PROGNOSIS | Health Supply Chains Are Understudied, Limiting Focus on Patients
Previously, this column has scrutinized the lack of accountability in hospital systems, health insurance companies, pharmaceutical manufacturers, pharmacy benefit managers (PBMs) and their negotiators for raising U.S. health care costs. However, far more financial incentives exist to overcharge consumers for medications and services, and scarcely discussed negotiators may be taking revenues at every stage of...
Pricing, politics and patients: the new drug affordability battle
The USA remains the outlier among wealthy drug markets. OECD data for 2023 put US retail pharmaceutical spending at $1,713 per person, against an OECD average of $766. Germany was at $1,158 and Switzerland at $1,061.
Psychedelic therapies are becoming mainstream. Deutsche Bank thinks this drug developer could triple
This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, according to a Deutsche Bank analyst.
Scientists Figured Out How to Turn Plastic Waste Into a Parkinson's Drug
From pollutants to pharmaceuticals.
‘Promise and Pitfalls’ of AI in health care at center of URI Pharmacy conference
KINGSTON, R.I. — March 27, 2026 — Despite its relative infancy among world-changing technologies in human history—the wheel, the printing press, electricity, the Internet—artificial intelligence has most rapidly become ubiquitous, already adopted by billions of people just a few short years after becoming publicly available. AI has infiltrated virtually all aspects of life, including health […]
Health-Care Costs Are Forcing Terrible Trade-Offs
Earlier this month, as I waited to pick up a prescription at my local CVS, I watched a man leave without his elderly father’s medication. The pharmacist had tried several tricks to lower the cost. It wasn’t enough. When the man heard the bottom line, he stuffed his hands in his pockets and, after a long, awkward silence, walked away.
The Pharmacy Business Model Is Breaking. States Are Scrambling To Fix It.
The crisis may be much broader than just independent pharmacies. The business of community pharmacy as a whole is under duress.
How to Turn a Chicken Egg Into a Drug Factory
A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.
Boehringer Ingelheim and Connecticut Science Center Launch an Innovation Lab to Advance STEM Education Across Connecticut
/PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Connecticut Science Center announced the launch of an Innovation Lab, presented by Boehringer, a...
Lightning Round: Sell Penn Entertainment
'Mad Money' host Jim Cramer weighs in on stocks including: Qnity Electronics, Rigel Pharmaceuticals, Penn Entertainment, Applied Digital, and more.
Pharma bribery corrupts health care, puts patients at risk, new review warns
Sham clinical studies, slush funds and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.
Cardinal Health (CAH) Emerged as a Key Contributor on Pharmaceutical Strength and Margin Expansion
Renaissance Investment Management, an investment management company, released its Q4 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The strategy faced a difficult fourth quarter of 2025, underperforming both the S&P 500, which gained 2.7%, and the Russell 1000 Growth Index as market leadership remained concentrated in […]
Grifols Plans IPO of U.S. Biopharma Business
The Spanish pharmaceutical company is looking to raise money to bolster its balance sheet and fund investments.
Imaging manufacturer Guerbet faces financial challenges following recent FDA warning
Regulators recently scolded the France-based pharmaceutical firm for safety issues that occurred at its plant in Raleigh, North Carolina, which produces imaging contrast agents.
Grifols approves IPO of its US biopharma business
Healthcare company Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business.
CVS Health and FTC Staff Agree to Proposed Insulin Settlement
The agreement would cover the company’s Caremark pharmacy benefit manager unit, which has denied wrongdoing.
Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109
/PRNewswire/ -- Apnimed, Inc., a pharmaceutical company developing an oral drug product candidate, AD109, that is designed to address a root cause of...
White House pitches pharma on pricing draft
Plus: Names of the candidates to lead the CDC
Formulating a Future: Finding a Calling in Pharmaceutical Science | Oberlin College and Conservatory
Chemistry major Alex Xie ’26 utilizes CELA’s research fellowships and scholarship advising to transition from campus labs to a future in pharmaceutical research.
D-FW business datebook for week of March 22
Earnings from GameStop, Commercial Metals and Lantern Pharma are part of a busy week.
UVA Health opens new pharmacy facility in Discovery Park
40,000-square-foot center can process up to 4,000 prescriptions per shift.
The R.I.-based pharmacy giant also owns health insurer Aetna and pharmacy benefit manager Caremark, allowing it to control how medications are priced, prescribed, and dispensed
CVS owns health insurer Aetna and pharmacy benefit manager Caremark, allowing it to control how medications are priced, prescribed, and dispensed.
CEO transition puts pharma business in the driver’s seat at Aptar
The company that turned the condiment world upside-down is now turning drug delivery on its nose at the same time it elevates its pharmaceutical leader to CEO.
SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment
RANCHO CORDOVA, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term growth strategy across three business units: small molecule, peptides, and viral vectors. SK pharmteco is sharpening its strategy to provide pharmaceutical and biotechnology partners with the financial strength, technical rigor, and operational infrastructure needed for long-term
Stada Hunts for Major Consumer Health Deal After Record Profit
German pharmaceutical firm Stada said it’s ready to make a major consumer health acquisition as it books record profit and transitions to new ownership.
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
CAMBRIDGE, England & BOSTON, March 17, 2026--Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided recent corporate updates.
The scientist who warned that profit, not science, decides which drugs reach patients
In a Genomic Press Interview published in Brain Medicine, Dr. Gabriella Gobbi, Professor of Psychiatry at McGill University, Canada Research Chair (Tier 1) in Therapeutics for Mental Health, and President-Elect of the Collegium Internationale of Neuropsychopharmacology (CINP), delivers a pointed warning: the greatest threat to drug discovery is not scientific failure but a financing system that abandons effective, affordable treatments whenever they cannot promise sufficient returns to investors. Across a career that began in central Italy and moved through Sardinia and Montreal, Dr. Gobbi has generated landmark research linking adolescent cannabis exposure to depression, identified novel melatonin receptor mechanisms in sleep and pain, and launched psychedelic neuroscience before it became fashionable. The interview reveals a scientist whose best questions have always begun at the bedside, and whose most urgent fears concern the structures that stand between discovery and patients.
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Advanced research and development of CUE-401 for IND (Investigational New Drug) readiness –CUE-401 is the Company’s lead asset for the treatment of autoimmune and inflammatory diseasesAppointed industry veteran Lucinda Warren as Chief Financial and Business OfficerRaised net proceeds of $10.2M through an underwritten public offeringAnnounced strategic collaboration and license agreement with ImmunoScape to develop breakthrough cell therapy approach for solid tumors – Entitled to receive upfront
Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
MOUNTAIN VIEW, Calif., March 16, 2026--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the full year ended December 31, 2025, and highlighted recent progress across its pipeline of clinical-stage product candidates.
Syngenta to build $120mn agricultural science centre in UK
Investment by Swiss-based group contrasts with pharma companies withdrawing funding from British research facilities
Scientists Discover Where Drug Residues End Up Inside Crops
Scientists discovered that crops exposed to trace pharmaceuticals in recycled water mostly stash the compounds in their leaves—not the parts we usually eat.
Cow Creek Umpqua Tribe opens new Health & Wellness Pharmacy in Roseburg
The Cow Creek Band of Umpqua Tribe of Indians celebrated a milestone in community healthcare Wednesday with a ribbon-cutting ceremony at the new Cow Creek Healt
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25
Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release full year 2025 financial results and provide business updates on Wednesday, March 25, 2026. The Company will host a conference call to discuss results that day at 4:30 PM ET.
Health Medicinals Expands Apotheco Medicinals as National Operations Platform
NEW YORK & CHICAGO, March 11, 2026--Unified pharmacy platform embedded in prescriber workflows, bringing commercial, personalized, and Rx-companion therapies together.
WSU inspires native youth to see themselves in health careers
Little Birds program introduces elementary schoolers to healthcare fields to encourage early interest in becoming doctors, nurses and pharmacists.
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Business Updates
Initiation of confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia is planned for Q2 2026, with topline data anticipated in 2H 2027BURLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today provided business updates and reported financial results for the fourth quarter and year ended Decembe
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production and...
Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
$250,000 top award goes to Connor Hill in America’s longest running and most distinguished science and math competition Top $250,000 Regeneron Science Talent Search Winner Named Regeneron and Society for Science announced that Connor Hill, 17, of State College, Pennsylvania, won the top award of $250,000 in the 2026 Regeneron Science Talent Search (STS), a program of Society for Science. TARRYTOWN, N.Y. and WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. and Societ
Fargo pharmacist files federal lawsuit against Sanford Health, alleges she was fired to avoid paying millions in medical bills
A federal complaint alleges Sanford violated ERISA, FMLA, the ADA, and Title VII.
Health Care Roundup: Market Talk
Find insight on Roche Holding, Zealand Pharma and more in the latest Market Talks covering the health care sector.
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
GLEN ALLEN, Va., March 06, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2025 fiscal year ended December 31, 2025. Key Highlights: Regulatory Progress: Achieved positive clinical study results from the AD04-103 pharmacokinetics (P
R.I. AG Neronha endorses Foulkes in primary against Governor McKee
McKee has criticized Foulkes over her role as CVS Pharmacy president in the opioid crisis, but Neronha said, “She did everything that she could to make this horrible situation better.”
CVS taps Google Cloud to roll out AI-powered health platform
CVS Health will launch an AI-enabled platform in partnership with Alphabet's Google Cloud unit that will bring together data from diverse sources to help customers manage their health in real time, they said on Thursday. Health100 will be an integrated health care engagement platform for customers, regardless of the pharmacy or insurer they use. The initial launch of Health100 will be in 2026, with details expected to be revealed at The Check Up, Google's annual health event later in March.
Health Care Roundup: Market Talk
Find insight on Bayer, Neuren Pharmaceuticals , and more in the latest Market Talks covering Health Care.
The science of structures: FSU chemist synthesizes complex molecule with potential for medicine, pharmaceutical applications
A Florida State University chemist has developed a method to rapidly assemble significantly complex natural molecules with potential in biomedical
New pharmacy professor working to advance mental health policy research
From data to decision-making, Philip Hughes is working to advance mental health policy research
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
ROCKVILLE, Md. & EDMONTON, Alberta, February 26, 2026--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced financial results for the three and twelve months ended December 31, 2025 and provided an update on recent business progress.
Datavault AI (DVLT), Wellgistics Health Expand Partnership to Launch Blockchain-Powered HaaS Model
Datavault AI Inc. (NASDAQ:DVLT) is one of the best penny stocks under $1 to buy right now. On February 23, Datavault AI and Wellgistics Health Inc. (NASDAQ:WGRX) announced an expansion of their partnership to develop a Healthcare-as-a-Service/HaaS model powered by blockchain-enabled smart contracts. This initiative builds on their existing PharmacyChain technology, which currently digitizes the […]
WashU to establish pharmacy school, absorb PharmD program from UHSP
Washington University in St. Louis and University of Health Sciences and Pharmacy announced they have entered into an agreement whereby WashU will assume control of UHSP. UHSP’s central program, the Doctor of Pharmacy, will become WashU’s 10th academic school, to be known as WashU St. Louis College of Pharmacy.
San Diego Festival of Science and Engineering brings industry leaders to Petco Park
Exhibitors include Ballet Folklorico Moncayo, Children’s Museum of Discovery and the U.S. Navy, plus major pharmaceutical companies like Bristol Myers Squibb and Genentech among others.
AbbVie to invest $380 million to expand US manufacturing in Illinois
AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its Illinois campus, expanding its domestic production capacity for its neuroscience and obesity medicines.
Girding against Keytruda cliff, Merck splits oncology into standalone business unit
The patent cliff for Keytruda is fast approaching in the U.S. Now, as Merck & Co. | The patent cliff for Keytruda is fast approaching in the U.S. Now, as Merck & Co. increasingly looks to life after its oncology megablockbuster, the company is honing its focus on new and upcoming medicines by splitting its core pharmaceutical business in two.